Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors.

Tyrel T. Smith, Howell F. Moffett, Sirkka B. Stephan, Cary F. Opel, Amy Dumigan, Xiuyun Jiang, Venu G. Pillarisetty, Smitha P. S. Pallai, Matthias Stephan *

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

139 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors.'. Together they form a unique fingerprint.

Medicine & Life Sciences